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A B S T R A C T
Background
Artificial formula can be manipulated to contain higher amounts of macro-nutrients than maternal breast milk but breast milk confers
important immuno-nutritional advantages for preterm or low birth weight (LBW) infants.
Objectives
To determine the effect of feeding preterm or LBW infants with formula compared with maternal breast milk on growth and develop-
mental outcomes.
Search methods
We used the standard strategy of Cochrane Neonatal to search the Cochrane Central Register of Controlled Trials (CENTRAL 2018,
Issue 9), and Ovid MEDLINE, Ovid Embase, Ovid Maternity & Infant Care Database, and CINAHL to October 2018. We searched
clinical trials databases, conference proceedings, and the reference lists of retrieved articles.
Selection criteria
Randomised or quasi-randomised controlled trials that compared feeding preterm or low birth weight infants with formula versus
maternal breast milk.
Data collection and analysis
Two review authors planned independently to assess trial eligibility and risk of bias, and extract data. We planned to analyse treatment
effects as described in the individual trials and report risk ratios and risk differences for dichotomous data, and mean differences for
continuous data, with 95% confidence intervals. We planned to use a fixed-effect model in meta-analyses and to explore potential
causes of heterogeneity in subgroup analyses. We planned to use the GRADE approach to assess the certainty of evidence.
Main results
We did not identify any eligible trials.
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Authors’ conclusions
There are no trials of formula versus maternal breast milk for feeding preterm or low birth weight infants. Such trials are unlikely to
be conducted because of the difficulty of allocating an alternative form of nutrition to an infant whose mother wishes to feed with her
own breast milk. Maternal breast milk remains the default choice of enteral nutrition because observational studies, and meta-analyses
of trials comparing feeding with formula versus donor breast milk, suggest that feeding with breast milk has major immuno-nutritional
advantages for preterm or low birth weight infants.
P L A I N L A N G U A G E S U M M A R Y
Formula versus maternal breast milk for feeding preterm or low birth weight infants
Review question
Does feeding preterm or low birth weight infants with formula rather than maternal breast milk affect growth and development?
Background
Artificial formulas can be manipulated to contain higher amounts of important nutrients such as protein than maternal breast milk
but newborn infants often find formula difficult to digest. Artificial formulas, furthermore, do not contain the antibodies and other
substances present in breast milk that protect the immature gut of preterm or low birth weight infants and reduce the risk of infection
and severe bowel problems. If preterm infants are fed with formula rather than maternal breast milk (breast-fed directly or mother’s
own expressed breast milk), this might increase the risk of these problems and adversely affect growth and development. Given these
concerns, we planned to review the evidence from clinical trials that compared formula versus maternal breast milk for feeding preterm
or low birth weight infants.
Study characteristics
In searches up to October 2018, we did not find any eligible randomised controlled trials.
Key results and conclusions
There are no trial data to answer this question. Since another Cochrane Review showed that feeding with formula compared to donor
breast milk increases the risk of serious gut problems in preterm or low birth weight infants, it is unlikely that families and clinicians
would consider it acceptable to allocate an infant to receive formula as an alternative to maternal breast milk when it is available.
B A C K G R O U N D
This review focuses on the comparison of feeding preterm or low
birth weight (LBW) infants with artificial formula versus mater-
nal (mother’s own) breast milk. The comparison of feeding with
formula versus donor breast milk is addressed in a separate review
(Quigley 2018). Healthcare professional or peer-led breastfeeding
support interventions for mothers of preterm or LBW infants have
been addressed in other reviews (McInnes 2008; Renfrew 2009;
Ahmed 2010).
Description of the condition
Early enteral feeding strategies, including the type of milk given to
infants, can affect important outcomes in preterm or LBW infants,
and especially very preterm or very low birth weight (VLBW) in-
fants who have limited nutrient reserves at birth and are subject
to physiological and metabolic stresses that increase their nutri-
ent needs (Agostoni 2010; Embleton 2017). Most very preterm
or VLBW infants accumulate nutrient deficits during their ini-
tial hospital stay and many infants are growth-restricted relative
to their term-born peers by the time they are ready to go home
(Embleton 2001; Horbar 2015). Growth deficits, which can per-
sist through childhood and adolescence, are associated with ad-
verse neurodevelopmental, cognitive, and educational outcomes
(Leppänen 2014).
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Description of the intervention
Maternal breast milk is the recommended form of enteral nu-
trition for preterm or LBW infants (Agostoni 2010; AAP 2012;
Cleminson 2015). In addition to macro- and micro-nutrients that
are optimised by evolution for digestion and absorption by hu-
man infants, maternal breast milk contains numerous ’immuno-
nutrients’ such as secretory immunoglobulin (Ig)A, lactoferrin, cy-
tokines, enzymes, growth factors, and leucocytes (Walsh 2019).
An important benefit of maternal breast milk for preterm or LBW
infants is that delivery of these immunological and growth factors
to the immature intestinal mucosa promotes post-natal physio-
logical, neuro-endocrinological, and metabolic adaptation (Jones
2007; Embleton 2017). Evidence from observational studies sug-
gests that feeding with maternal breast milk rather than formula
is associated with a reduced risk of serious adverse outcomes in-
cluding necrotising enterocolitis and infection in very preterm and
VLBW infants (Lucas 1990; Battersby 2017). A Cochrane Review
of trials that compared feeding preterm or LBW infants with for-
mula versus donor breast milk showed that formula feeding was
associated with a near doubling of the risk of severe necrotising
enterocolitis (Quigley 2018).
The nutritional requirements of preterm or LBW infants, and es-
pecially very preterm and VLBW infants, may not be met by en-
teral feeding with maternal breast milk alone (Agostoni 2010).
Maternal breast milk varies in energy and protein content depend-
ing upon the stage of lactation at which it is collected, the dura-
tion of lactation, and the method of storage and delivery. Many of
the processes involved in handling maternal breast milk, includ-
ing refrigeration, freeze-thawing, and pasteurisation, can reduce
its macro-nutrient and immuno-nutrient content (Zachariassen
2013; Gidrewicz 2014). Supplementation of maternal breast milk
with nutrient fortifiers (typically extracted fromcowmilk) is an op-
tion for increasing nutrient density (Klingenberg 2012; Tudehope
2013; Underwood 2013). Although this results in faster short-
term growth, uncertainty remains about whether fortification us-
ing bovine milk extracts increases the risk of enteral feed intoler-
ance or necrotising enterocolitis in very preterm or VLBW infants
(Brown 2016; Ellis 2019).
Intervention formula
As an alternative to breastmilk, a variety of artificial formulas (usu-
ally modified cow milk) for feeding preterm or LBW infants are
available commercially (Agostoni 2010; Tudehope 2012). These
vary in energy, protein and micro-nutrient content and, broadly,
can be categorised as:
• standard ’term’ formulas; designed for term infants, based
on the composition of mature breast milk the typical energy
content is between about 67 and 70 kCal/100 mL;
• nutrient-enriched ’preterm’ formulas; designed for preterm
infants to provide nutrient intakes to match intra-uterine
accretion rates these are energy-enriched (typically up to
about 80 kCal/100 mL) and are variably protein- and mineral-
enriched.
How the intervention might work
Artificial formula, particularly nutrient-enriched ’preterm’ for-
mula, might provide consistently higher levels of nutrients than
maternal breast milk does. However, artificial formulas do not
contain the same immuno-nutritional factors that are present in
maternal breast milk (Tudehope 2012; Underwood 2013). Fur-
thermore, although bovine proteins, carbohydrates and lipids in
artificial formulas are modified to improve digestibility for new-
born infants, these are less likely to be tolerated than human milk
macro-nutrients, especially by the immature preterm intestine.
Formula feeding might therefore delay the functional adaptation
of the gastrointestinal tract and disrupt the patterns of microbial
colonisation (Embleton 2017). Intestinal dysmotility and dysbio-
sis might exacerbate feed intolerance and delay the establishment
of enteral feeding independent of parenteral nutrition ( Pammi
2017). Prolonged parenteral nutrition is associated with infectious
and metabolic complications that increase mortality and morbid-
ity, prolong hospital stay, and adversely affect growth and devel-
opment (Walsh 2019).
Why it is important to do this review
Given the potential for the type of enteral nutrition to affect im-
portant outcomes for preterm or LBW infants, and since uncer-
tainty exists about the balance between the putative benefits and
harms, an attempt to detect, appraise and synthesise evidence from
randomised controlled trials is merited.
O B J E C T I V E S
To determine the effect of feeding preterm or LBW infants with
formula compared with maternal breast milk on growth and de-
velopmental outcomes.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Controlled trials utilizing either random or quasi-random patient
allocation.
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Types of participants
Preterm (< 37 weeks’ gestational age) or LBW (< 2500 g) infants.
Types of interventions
Feeding with formula milk versus maternal (mother’s own) ex-
pressed milk.
Types of outcome measures
Primary outcomes
Growth
• Rates of weight gain, linear growth, head growth or
skinfold thickness growth during initial hospitalisation, and z-
score at 36 weeks’ or longer post-menstrual age
• Weight, height or head circumference (or proportion of
infants who remain below the 10th percentile for the index
population’s distribution), assessed at intervals following hospital
discharge
Neurodevelopment
• Death or severe neurodevelopmental disability defined as
any one or combination of the following: non-ambulant cerebral
palsy, developmental quotient more than two standard
deviations below the population mean, and blindness (visual
acuity < 6/60) or deafness (any hearing impairment requiring or
unimproved by amplification)
• Neurodevelopmental scores in children aged at least 12
months, measured using validated assessment tools such as main
domains (cognitive, motor, language) of Bayley Scales of Infant
and Toddler Development, Third Edition (Bayley-III)
• Cognitive and educational outcomes in children ≥ five
years old
Necrotising enterocolitis confirmed at surgery or autopsy or diag-
nosed by at least two of the following clinical features ( Kliegman
1987).
• Abdominal radiograph showing pneumatosis intestinalis or
gas in the portal venous system or free air in the abdomen
• Abdominal distension with abdominal radiograph with
gaseous distension or frothy appearance of bowel lumen (or both)
• Blood in stool
• Lethargy, hypotonia or apnoea (or combination of these)
Secondary outcomes
• Death in the neonatal period (up to 28 days) and death
prior to hospital discharge
• Feed intolerance during the trial intervention period that
results in cessation in enteral feeding for > 4 hours
• Time after birth to establish full enteral feeding
(independently of parenteral nutrition)
• Invasive infection as determined by culture of bacteria or
fungus from blood, cerebrospinal fluid, or from a normally
sterile body space
• Duration of birth hospitalisation (days)
Search methods for identification of studies
We used the Cochrane Neonatal standard search strategy.
Electronic searches
We searched the Cochrane Central Register of Controlled Tri-
als (CENTRAL; 2018, Issue 9) in the Cochrane Library, Ovid
MEDLINE (1946 to 1 October 2018), OVID Embase (1980 to
1 October 2018), and OVID Maternity & Infant Care Database
(1971 to 1 October 2018), and the Cumulative Index to Nurs-
ing and AlliedHealth Literature Plus (CINAHL) via Ebsco (1982
to 21 September 2018) using a combination of text words and
MeSH terms described in Appendix 1. We limited the search out-
puts with relevant search filters for clinical trials as recommended
in the Cochrane Handbook for Systematic Reviews of Interventions (
Higgins 2017). We did not apply any language restrictions.
We searched ClinicalTrials.gov and the World Health Or-
ganization’s International Clinical Trials Registry Platform (
www.who.int/ictrp/en) for completed or ongoing trials.
Searching other resources
We examined reference lists in previous reviews and included stud-
ies. We searched the proceedings of the annual meetings of the
Pediatric Academic Societies (1993 to 2019), the European So-
ciety for Paediatric Research (1995 to 2019), the Royal College
of Paediatrics and Child Health (2000 to 2019), and the Perina-
tal Society of Australia and New Zealand (2000 to 2019). Trials
reported only as abstracts were eligible if sufficient information
was available from the report, or from contact with the authors,
to fulfil the inclusion criteria.
Data collection and analysis
We used the standard methods of Cochrane Neonatal (
neonatal.cochrane.org).
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Selection of studies
We screened the title and abstract of all studies identified by the
above search strategy and two review authors (JB, VW) indepen-
dently assessed the full articles for all potentially relevant trials.
We excluded those studies that did not meet all of the inclusion
criteria and we stated the reason for exclusion. We discussed any
disagreements until consensus was achieved. We illustrated the
screening and selection outcomes in a flowchart (Figure 1).
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Figure 1. Study flow diagram: review update
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Data extraction and management
Two review authors (JB, WM) planned to extract data indepen-
dently using a data collection form to aid extraction of infor-
mation on design, methodology, participants, interventions, out-
comes and treatment effects from each included study.We planned
to discuss any disagreements until we reached a consensus. If data
from the trial reports were insufficient, we planned to contact the
trialists for further information.
Assessment of risk of bias in included studies
Two review authors (JB and VW) planned to independently assess
the risk of bias (low, high, or unclear) of all included trials using
the Cochrane ‘Risk of bias’ tool (Higgins 2011) for the following
domains.
• Sequence generation (selection bias)
• Allocation concealment (selection bias)
• Blinding of participants and personnel (performance bias)
• Blinding of outcome assessment (detection bias)
• Incomplete outcome data (attrition bias)
• Selective reporting (reporting bias)
• Any other bias
We planned to resolve disagreements by discussion or by includ-
ing a third review author (WM). See Appendix 2 for a detailed
description of risk of bias for each domain.
Measures of treatment effect
Weplanned to calculate risk ratios and risk differences for dichoto-
mous data and mean differences for continuous data, with respec-
tive 95% confidence intervals. If deemed appropriate to combine
two or more study arms, we planned to obtain the treatment ef-
fects from the combined data using the methods described in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011). We planned to determine the number needed to treat for
an additional beneficial outcome or the number needed to treat
for an additional harmful outcome for each statistically significant
risk difference.
Unit of analysis issues
We specified the unit of analysis as the participating infant in in-
dividually randomised trials and the neonatal unit (or subunit) for
cluster-randomised controlled trials. For cluster trials, we planned
to undertake analyses at the level of the individual while account-
ing for the clustering in the data using the methods recommended
in the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011).
Dealing with missing data
Where data were missing, and could not be derived as described,
we planned to approach the analysis of missing data as follows.
• Contact the original study investigators to request the
missing data
• Where possible, impute missing standard deviations (SD)
using the coefficient of variation or calculate the SD from other
statistics including standard errors, confidence intervals, t values
and P values
• If the data were likely to be missing at random, analyse the
data without imputing any missing values
• If the data were not likely to be missing at random, impute
the missing outcomes with replacement values, assuming all to
have a poor outcome
Assessment of heterogeneity
Two review authors (JB and VW) planned to assess clinical het-
erogeneity, with a meta-analysis conducted only when both agreed
that study participants, interventions and outcomes were suffi-
ciently similar.
We planned to examine the treatment effects of individual trials
and heterogeneity between trial results by inspecting the forest
plots. We planned to calculate the I² statistic for each analysis to
quantify inconsistency across studies and describe the percentage
of variability in effect estimates that may be due to heterogeneity
rather than to sampling error. If we detectedmoderate or high het-
erogeneity (I² > 50%), we planned to explore the possible causes
(for example, differences in study design, participants, interven-
tions or completeness of outcome assessments).
Assessment of reporting biases
If more than 10 trials were included in ameta-analysis, we planned
to examine a funnel plot for asymmetry.
Data synthesis
We planned to use a fixed-effect model for meta-analysis (as per
Cochrane Neonatal policy). Where moderate or high heterogene-
ity existed, we planned to examine the potential causes in sub-
group and sensitivity analyses.
Quality of evidence
We planned to use the GRADE approach, as outlined in the
GRADE Handbook (Schünemann 2013), to assess the certainty
of evidence for the primary outcomes (Appendix 3). We planned
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to use the GRADEpro GDTGuideline Development Tool to cre-
ate a ‘Summary of findings’ table to report the quality of the evi-
dence.
Subgroup analysis and investigation of heterogeneity
We planned these analyses of trials to assess subgroup differences
for:
• (i) ’term’ formula milk (up to 72 kCal/100 mL) or (ii)
’preterm’ formula milk (> 72 kCal/100 mL) versus maternal
breast milk;
• formula versus (i) unfortified or (ii) nutrient-fortified
maternal breast milk.
R E S U L T S
Description of studies
We did not find any studies that fulfilled the eligibility criteria.
We excluded nine studies (Characteristics of excluded studies).
Six were not randomised trials on review of the full text (Carey
1987; Greer 1988; Lucas 1990; Armand 1996; O’Connor 2003;
Marseglia 2014). One was a trial of early versus later use of breast
milk (Tewari 2018). Two studies were excluded because the infants
were allocated to receive formula versus a mixture of maternal and
donor breast milk (Narayanan 1982; Svenningsen 1982).
Risk of bias in included studies
Wewere unable to assess risk of bias as there were no eligible trials.
Effects of interventions
We were not able to calculate the effects of interventions as there
were no eligible trials.
D I S C U S S I O N
Summary of main results
We did not identify any randomised controlled trials of formula
versusmaternal breastmilk for feeding preterm or lowbirth weight
(LBW) infants. This is likely to be due to reluctance of families,
clinicians, caregivers, and researchers to assess an intervention that
results in infants not receiving the immuno-nutritional benefits of
breastmilk (Walsh 2019).Observational studies have foundhigher
rates of necrotising enterocolitis in infants fed formula compared
with maternal breast milk (Lucas 1990; Battersby 2017). Meta-
analysis of data from randomised controlled trials indicates that
feeding with formula, compared with donor breast milk, leads to
higher rates of feed intolerance and necrotising enterocolitis in
preterm infants (Quigley 2018). Since maternal breast milk con-
tains higher levels of putative immuno-protective factors (secre-
tory IgA, lysozyme, lactoferrin, epidermal growth factors) than
donor breast milk, it is plausible that feeding with maternal breast
milk will have the same or greater protective effect. Furthermore,
if there is concern regarding the nutritional adequacy of maternal
breast milk, infants can receive supplemental nutrition via multi-
component fortification although it is uncertain if this compro-
mises the non-nutritional benefits of breast milk (Brown 2016).
In resource-poor countries, where the risk of infection in the
neonatal period is much higher than in resource-rich countries,
the anti-infective properties of maternal breast milk might con-
fer further advantages for preterm or LBW infants. In India, a
randomised trial in LBW infants “at risk of infection” found that
serious infections (diarrhoea, pneumonia, septicaemia) were less
common in infants allocated to receive “expressed human milk”
versus formula (Narayanan 1982). “Expressed humanmilk” in this
trial referred to a mixture of maternal and donor breast milk. As
these could not be separated into subgroups, the data could not
be included in the review.
Potential biases in the review process
Themain concern with the review process is the possibility that we
did not detect trials that are not indexed in themajor bibliographic
electronic databases. We attempted to minimise this threat by
screening the reference lists of included trials and related reviews
and searching the proceedings of the major international perinatal
conferences to identify trial reports that are not published in full
form in academic journals. However, we cannot be sure whether
other trials have been undertaken, but not reported or indexed,
and the concern remains that unpublished trials are not likely to
have detected statistically significant or clinically important effects.
Agreements and disagreements with other
studies or reviews
We did not identify another systematic review of randomised con-
trolled trials of feeding preterm or VLBW infants with formula
versus maternal breast milk.
A U T H O R S ’ C O N C L U S I O N S
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Implications for practice
There are no data from randomised controlled trials to determine
whether feeding preterm or LBW infants with formula versus ma-
ternal breast milk affects growth, development, or other important
outcomes. Maternal breast milk remains the default choice of nu-
trition for feeding preterm or LBW infants because of its putative
immuno-nutrient advantages, and because nutrient fortification
of breast milk can address concerns about nutrient content and
growth rates.
Implications for research
Mothers who wish to breast feed, and their health care advisors,
would require very clear evidence that feeding with formula had
major advantages for their infants before electing not to feed (or
to reduce feeding) with maternal breast milk. It is unlikely that
equipoise exists amongst families, mothers, clinicians and care-
givers to undertake such a trial. Data from observational studies,
and meta-analyses of trials that compared feeding with formula
milk versus donor breast milk, suggest that feeding with breast
milk has important advantages for preterm or LBW infants.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Armand 1996 Not randomised
Carey 1987 Not randomised
Greer 1988 Not randomised
Lucas 1990 Not randomised
Marseglia 2014 Not randomised
Narayanan 1982 Human-milk-fed infants received a mixture of maternal and donor breast milk
O’Connor 2003 Not randomised
Svenningsen 1982 Control group received maternal and donor breast milk
Tewari 2018 Randomised trial of early versus late feeding of very preterm infants with breast milk
A P P E N D I C E S
Appendix 1. Electronic search strategy
Milk or formula search strategies
Database Date of search Results Results after deduplication
MEDLINE (Ovid) 1 October 2018 2537 2480
Embase (Ovid) 1 October 2018 2947 1471
Maternity and Infant Care
(Ovid)
1 October 2018 2336 1068
CINAHL Plus (Ebsco) 21 September 2018 2770 1505
CENTRAL (Wiley) 1 October 2018 1875 449
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(Continued)
total 12465 6973
MEDLINE(R) and Epub Ahead of Print, In-Process & Other Non-Indexed Citations and Daily
via Ovid ( ovidsp.ovid.com)
1946 to 28 September 2018
Searched on: 1 October 2018
Records retrieved: 2537
1 exp Infant, Premature/ (51111)
2 exp Infant, Low Birth Weight/ (31685)
3 Premature Birth/ (11274)
4 (preterm or preterms or pre term or pre terms).ti,ab. (65706)
5 (preemie$ or premie or premies).ti,ab. (150)
6 prematur$.ti,ab. (131848)
7 (low adj3 (birthweight$ or birth weight$)).ti,ab. (31674)
8 (lbw or vlbw or elbw).ti,ab. (7485)
9 or/1-8 (219368)
10 Infant Formula/ (3933)
11 formula$.ti,ab. (277253)
12 10 or 11 (278195)
13 9 and 12 (4365)
14 Milk, Human/ (17874)
15 Milk Banks/ (422)
16 (breastmilk$ or milk$).ti,ab. (116057)
17 or/14-16 (119637)
18 9 and 17 (5756)
19 13 or 18 (8298)
20 randomized controlled trial.pt. (468895)
21 controlled clinical trial.pt. (92668)
22 randomized.ab. (422504)
23 placebo.ab. (192035)
24 drug therapy.fs. (2050146)
25 randomly.ab. (297839)
26 trial.ab. (440111)
27 groups.ab. (1836626)
28 or/20-27 (4287670)
29 exp animals/ not humans/ (4499073)
30 28 not 29 (3706627)
31 19 and 30 (2537)
Embase
via Ovid ( ovidsp.ovid.com)
1974 to 28 September 2018
Searched on: 1 October 2018
Records retrieved: 2947
1 prematurity/ (89190)
2 exp low birth weight/ (54784)
3 (preterm or preterms or pre term or pre terms).ti,ab. (90499)
4 (preemie$ or premie or premies).ti,ab. (224)
5 prematur$.ti,ab. (168322)
6 (low adj3 (birthweight$ or birth weight$)).ti,ab. (39175)
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7 (lbw or vlbw or elbw).ti,ab. (10058)
8 1 or 2 or 3 or 4 or 5 or 6 or 7 (288691)
9 artificial milk/ (12531)
10 formula$.ti,ab. (344884)
11 9 or 10 (348727)
12 8 and 11 (6305)
13 breast milk/ (24259)
14 milk bank/ (110)
15 (breastmilk$ or milk$).ti,ab. (125678)
16 or/13-15 (130935)
17 8 and 16 (7348)
18 12 or 17 (11077)
19 randomized controlled trial/ (513947)
20 controlled clinical trial/ (457995)
21 Random$.ti,ab. (1330412)
22 randomization/ (79416)
23 intermethod comparison/ (238126)
24 placebo.ti,ab. (275734)
25 (compare or compared or comparison).ti. (459192)
26 ((evaluated or evaluate or evaluating or assessed or assess) and (compare or compared or comparing or comparison)).ab. (1792923)
27 (open adj label).ti,ab. (65919)
28 ((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab. (209762)
29 double blind procedure/ (153064)
30 parallel group$1.ti,ab. (22153)
31 (crossover or cross over).ti,ab. (93846)
32 ((assign$ or match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or partici-
pant$1)).ti,ab. (287519)
33 (assigned or allocated).ti,ab. (337932)
34 (controlled adj7 (study or design or trial)).ti,ab. (299382)
35 (volunteer or volunteers).ti,ab. (225794)
36 human experiment/ (413882)
37 trial.ti. (251429)
38 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 (4358702)
39 (rat or rats or mouse or mice or rodent or rodents or swine or porcine or murine or sheep or lamb or lambs or ewe or ewes or pig
or pigs or piglet or piglets or sow or sows or rabbit or rabbits or cat or cats or kitten or kittens or dog or dogs or puppy or puppies or
monkey or monkeys or horse or horses or foal or foals or equine or calf or calves or cattle or heifer or heifers or hamster or hamsters or
chicken or chickens or livestock or panda or pandas or buffalo$ or baboon$).ti. (2142499)
40 38 not 39 (4076303)
41 18 and 40 (2947)
Maternity & Infant Care Database (MIDIRS)
via Ovid ( ovidsp.ovid.com)
1971 to August 2018
Searched on: 1 October 2018
Records retrieved: 2336
1 (preterm or preterms or pre term or pre terms).mp. (24799)
2 (preemie$ or premie or premies).mp. (52)
3 prematur$.mp. (22144)
4 (low adj3 (birthweight$ or birth weight$)).mp. (11391)
5 (lbw or vlbw or elbw).mp. (2911)
6 1 or 2 or 3 or 4 or 5 (39839)
7 formula$.mp. (6112)
8 6 and 7 (1052)
9 (breastmilk$ or milk$).mp. (8742)
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10 6 and 9 (1857)
11 8 or 10 (2336)
CINAHL Complete
via Ebsco ( www.ebsco.com/products/research-databases)
Inception to 20180919
Searched on: 21 September 2018
Records retrieved: 2770
S1 (MH “Infant, Premature”) 18,840
S2 (MH “Infant, Low Birth Weight+”) 11,604
S3 TI ( preterm or preterms or pre-term or pre-terms ) OR AB ( preterm or preterms or pre-term or pre-terms) 24,932
S4 TI ( preemie* or premie or premies ) OR AB ( preemie* or premie or premies ) 254
S5 TI prematur* OR AB prematur* 23,780
S6 TI ( low N3 (birthweight* or birth-weight*) ) OR AB ( low N3 (birthweight* or birth-weight*) ) 9,526
S7 TI ( lbw or vlbw or elbw ) OR AB ( lbw or vlbw or elbw ) 2,560
S8 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 57,624
S9 (MH “Infant Formula”) 3,535
S10 TI formula* OR AB formula* 36,707
S11 S9 OR S10 38,406
S12 S8 AND S11 1,355
S13 (MH “Milk, Human+”) 4,886
S14 (MH “Milk Banks”) 434
S15 TI ( breastmilk* or milk* ) OR AB ( breastmilk* or milk* ) 13,874
S16 S13 OR S14 OR S15 15,557
S17 S8 AND S16 2,069
S18 S12 OR S17 2,817
S19 TI (rat or rats or mouse or mice or hamster or hamsters or dog or dogs or cat or cats or sheep or lamb or lambs or pig or pigs or
baboon*) 64,810
S20 S18 not S19 2,770
CENTRAL
via Wiley ( www.wiley.com)
Issue 9 of 12, September 2018
Searched on: 1 October 2018
Records retrieved: 1875
#1 MeSH descriptor: [Infant, Premature] explode all trees 3387
#2 MeSH descriptor: [Infant, Low Birth Weight] explode all trees 2036
#3 MeSH descriptor: [Premature Birth] this term only 1028
#4 (preterm or preterms or pre next term or pre next terms):ti,ab,kw 10114
#5 (preemie* or premie or premies):ti,ab,kw 34
#6 prematur*:ti,ab,kw 18080
#7 (low near/3 (birthweight* or birth next weight*)):ti,ab,kw 4473
#8 (lbw or vlbw or elbw):ti,ab,kw 1377
#9 {OR #1-#8} 23404
#10 MeSH descriptor: [Infant Formula] this term only 531
#11 formula*:ti,ab,kw 30754
#12 #10 or #11 30754
#13 #9 and #12 1252
#14 MeSH descriptor: [Milk, Human] this term only 926
#15 MeSH descriptor: [Milk Banks] this term only 5
#16 (breastmilk* or milk*):ti,ab,kw 8086
#17 #14 or #15 or #16 8086
#18 #9 and #17 1339
#19 #13 or #18 2017
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#20 #13 or #18 in Trials 1875
-------------------------------------------------------------
Appendix 2. ’Risk of bias’ tool
1. Sequence generation (checking for possible selection bias). Was the allocation sequence adequately generated?
For each included study, we categorised the method used to generate the allocation sequence as:
• low risk (any truly random process, e.g. random number table; computer random number generator);
• high risk (any non-random process, e.g. odd or even date of birth; hospital or clinic record number); or
• unclear risk.
2. Allocation concealment (checking for possible selection bias). Was allocation adequately concealed?
For each included study, we categorised the method used to conceal the allocation sequence as:
• low risk (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);
• high risk (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth); or
• unclear risk.
3. Blinding of participants and personnel (checking for possible performance bias). Was knowledge of the allocated intervention
adequately prevented during the study?
For each included study, we categorised the methods used to blind study participants and personnel from knowledge of which
intervention a participant received. Blinding was assessed separately for different outcomes or class of outcomes. We categorised the
methods as:
• low risk, high risk or unclear risk for participants; and
• low risk, high risk or unclear risk for personnel.
4. Blinding of outcome assessment (checking for possible detection bias). Was knowledge of the allocated intervention adequately
prevented at the time of outcome assessment?
For each included study, we categorised the methods used to blind outcome assessment. Blinding was assessed separately for different
outcomes or class of outcomes. We categorised the methods as:
• low risk for outcome assessors;
• high risk for outcome assessors; or
• unclear risk for outcome assessors.
5. Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations). Were
incomplete outcome data adequately addressed?
For each included study and for each outcome, we described the completeness of data including attrition and exclusions from the
analysis. We noted whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with
the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across
groups or were related to outcomes. Where sufficient information was reported or supplied by the trial authors, we re-included missing
data in the analyses. We categorised the methods as:
• low risk (< 20% missing data);
• high risk (≥ 20% missing data); or
• unclear risk.
6. Selective reporting bias. Are reports of the study free of suggestion of selective outcome reporting?
For each included study, we described how we investigated the possibility of selective outcome reporting bias and what we found. For
studies in which study protocols were published in advance, we compared prespecified outcomes versus outcomes eventually reported
in the published results. If the study protocol was not published in advance, we contacted study authors to gain access to the study
protocol. We assessed the methods as:
• low risk (where it is clear that all of the study’s prespecified outcomes and all expected outcomes of interest to the review have
been reported);
• high risk (where not all the study’s prespecified outcomes have been reported; one or more reported primary outcomes were not
prespecified outcomes of interest and are reported incompletely and so cannot be used; study fails to include results of a key outcome
that would have been expected to have been reported); or
• unclear risk.
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7. Other sources of bias. Was the study apparently free of other problems that could put it at a high risk of bias?
For each included study, we described any important concerns we had about other possible sources of bias (for example, whether there
was a potential source of bias related to the specific study design or whether the trial was stopped early due to some data-dependent
process). We assessed whether each study was free of other problems that could put it at risk of bias as:
• low risk;
• high risk;
• unclear risk.
If needed, we explored the impact of the level of bias through undertaking sensitivity analyses.
Appendix 3. GRADE
GRADE considers that evidence from randomised controlled trials is high quality, but that assessment may be downgraded based on
consideration of any of five areas.
• Design (risk of bias).
• Consistency across studies.
• Directness of the evidence.
• Precision of estimates.
• Presence of publication bias.
This results in an assessment of the quality of a body of evidence in one of four grades.
1. High: we are very confident that the true effect lies close to that of the estimate of the effect.
2. Moderate: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but
there is a possibility that it is substantially different.
3. Low: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
4. Very low: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the
estimate of effect.
WH A T ’ S N E W
Date Event Description
2 July 2019 New citation required but conclusions have not changed No trials identified. Conclusions are unchanged.
2 July 2019 New search has been performed Search updated in October 2018.
H I S T O R Y
Protocol first published: Issue 1, 2001
Review first published: Issue 3, 2001
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Date Event Description
12 June 2008 Amended Converted to new review format.
9 July 2007 New search has been performed This reviewupdates the review “Formulamilk versus preterm
humanmilk for feeding preterm or low birth weight infants”
published in The Cochrane Library, Issue 3, 2001 (Hender-
son 2001).
In this update, the structure of the review has been revised
in the following manner:
1. The comparison description is now “formula milk ver-
sus maternal breast milk.” A companion review addresses
the comparison of “formula milk versus donor breast milk”
(Quigley 2007).
2. The inclusion criteria includes trials that compared feed-
ing with formula versus maternal breast milk as a sole diet or
as a supplement to formula milk (previous review restricted
to sole diet).
No eligible trials were identified on updated search. The
previous review had identified a trial that compared feeding
with formula milk versus donor preterm milk. This trial
is no longer eligible for inclusion but is now included in
the companion review of “formula milk versus donor breast
milk” (Quigley 2007)
9 July 2007 New citation required and conclusions have changed Substantive amendment
C O N T R I B U T I O N S O F A U T H O R S
William McGuire (WM) and Mary Anthony developed the protocol and undertook the original review in 2000. Ginny Henderson
and WM updated the review in 2003 and 2007. Jennifer Brown and Verena Walsh updated the review in 2019.
D E C L A R A T I O N S O F I N T E R E S T
Core editorial and administrative support for this review has been provided by a grant from The Gerber Foundation. The Gerber
Foundation is a separately endowed, private foundation, distinct from the Gerber Products Company. The grantor has no input on
the content of the review or the editorial process.
In order to maintain the utmost editorial independence for this Cochrane Review, an editor outside of the Cochrane Neonatal core
editorial team who is not receiving any financial remuneration from the grant, Dr. Mohan Pammi, was the Sign-off Editor for this
review. A Senior Editor from the Cochrane Children and Families Network, Robert Boyle, assessed and signed off on this Cochrane
Review.
18Formula versus maternal breast milk for feeding preterm or low birth weight infants (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S O U R C E S O F S U P P O R T
Internal sources
• Centre for Reviews and Dissemination, University of York, UK.
External sources
• National Institute for Health Research (NIHR), UK.
This report is independent research funded by a UK NIHR Cochrane Programme Grant (16/114/03). The views expressed in this
publication are those of the review authors and are not necessarily those of the National Health Service, the NIHR, or the UK
Department of Health.
• Vermont Oxford Network, USA.
Cochrane Neonatal Reviews are produced with support from Vermont Oxford Network, a worldwide collaboration of health
professionals dedicated to providing evidence-based care of the highest quality for newborn infants and their families.
• The Gerber Foundation, USA.
Editorial support for this review, as part of a suite of preterm nutrition reviews, has been provided by a grant from The Gerber
Foundation. The Gerber Foundation is a separately endowed, private, 501(c)(3) foundation not related to Gerber Products Company
in any way.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We added the methodology and plan for ’Summary of findings’ tables and GRADE recommendations, which were not included in the
original protocol.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Enteral Nutrition; ∗Infant Food; ∗Infant, Low Birth Weight; ∗Infant, Premature; ∗Milk, Human; Growth
MeSH check words
Humans; Infant, Newborn
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